Pharmadrug Inc. (PHRX.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -13.2 Million CAD | -330.84% |
| 2022 | -3.06 Million CAD | 47.83% |
| 2021 | -5.87 Million CAD | -6.53% |
| 2020 | -5.51 Million CAD | 15.68% |
| 2019 | -6.53 Million CAD | -68.29% |
| 2018 | -3.88 Million CAD | -3283.45% |
| 2017 | -114.83 Thousand CAD | 98.47% |
| 2016 | -7.51 Million CAD | -1795.09% |
| 2015 | -396.44 Thousand CAD | 77.22% |
| 2014 | -1.74 Million CAD | -326.39% |
| 2013 | -408.15 Thousand CAD | -106.65% |
| 2012 | -197.51 Thousand CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -496.99 Thousand CAD | 95.96% |
| 2024 Q2 | -131.08 Thousand CAD | 71.02% |
| 2023 Q4 | -12.3 Million CAD | -4000.77% |
| 2023 Q1 | -72.03 Thousand CAD | -103.53% |
| 2023 Q2 | -419.97 Thousand CAD | -482.99% |
| 2023 Q3 | -300 Thousand CAD | 28.57% |
| 2023 FY | -13.2 Million CAD | -330.84% |
| 2022 Q3 | -3.23 Million CAD | 43.26% |
| 2022 Q4 | 2.03 Million CAD | 163.07% |
| 2022 FY | -3.06 Million CAD | 47.83% |
| 2022 Q1 | -2.05 Million CAD | -44.93% |
| 2022 Q2 | -5.69 Million CAD | -176.91% |
| 2021 Q4 | -1.41 Million CAD | -7.36% |
| 2021 FY | -5.87 Million CAD | -6.53% |
| 2021 Q2 | -1.14 Million CAD | 34.15% |
| 2021 Q3 | -1.32 Million CAD | -15.48% |
| 2021 Q1 | -1.73 Million CAD | 33.63% |
| 2020 Q4 | -2.62 Million CAD | -177.59% |
| 2020 Q3 | -943.93 Thousand CAD | 37.93% |
| 2020 Q2 | -1.52 Million CAD | -1033.63% |
| 2020 Q1 | -134.14 Thousand CAD | 96.16% |
| 2020 FY | -5.51 Million CAD | 15.68% |
| 2019 Q3 | -436.23 Thousand CAD | 67.82% |
| 2019 FY | -6.53 Million CAD | -68.29% |
| 2019 Q4 | -3.49 Million CAD | -701.74% |
| 2019 Q2 | -1.35 Million CAD | -55.84% |
| 2019 Q1 | -869.77 Thousand CAD | -28.31% |
| 2018 Q4 | -677.88 Thousand CAD | 76.46% |
| 2018 FY | -3.88 Million CAD | -3283.45% |
| 2018 Q3 | -2.88 Million CAD | -2273.39% |
| 2018 Q2 | -121.35 Thousand CAD | -50.31% |
| 2018 Q1 | -80.73 Thousand CAD | -139.91% |
| 2017 Q2 | -23.51 Thousand CAD | 11.46% |
| 2017 Q4 | -33.65 Thousand CAD | -221.67% |
| 2017 Q3 | -10.46 Thousand CAD | 55.5% |
| 2017 FY | -114.83 Thousand CAD | 98.47% |
| 2017 Q1 | -26.55 Thousand CAD | 51.11% |
| 2016 Q3 | -163.69 Thousand CAD | 97.74% |
| 2016 Q1 | -70.73 Thousand CAD | -160.59% |
| 2016 Q2 | -7.25 Million CAD | -10152.02% |
| 2016 FY | -7.51 Million CAD | -1795.09% |
| 2016 Q4 | -54.31 Thousand CAD | 66.82% |
| 2015 FY | -396.44 Thousand CAD | 77.22% |
| 2015 Q4 | -27.14 Thousand CAD | -149.11% |
| 2015 Q3 | 55.26 Thousand CAD | 139.22% |
| 2015 Q2 | -140.9 Thousand CAD | 34.71% |
| 2015 Q1 | -215.82 Thousand CAD | -127.25% |
| 2014 Q3 | -672.26 Thousand CAD | -179.41% |
| 2014 Q1 | -463.25 Thousand CAD | -27.19% |
| 2014 FY | -1.74 Million CAD | -326.39% |
| 2014 Q4 | -94.97 Thousand CAD | 85.87% |
| 2014 Q2 | -240.6 Thousand CAD | 48.06% |
| 2013 Q4 | -364.21 Thousand CAD | 13.31% |
| 2013 Q2 | -26.74 Thousand CAD | 56.58% |
| 2013 Q1 | -61.6 Thousand CAD | -161.39% |
| 2013 FY | -408.15 Thousand CAD | -106.65% |
| 2013 Q3 | -420.15 Thousand CAD | -1470.89% |
| 2012 FY | -197.51 Thousand CAD | 0.0% |
| 2012 Q3 | 5449.00 CAD | 129.15% |
| 2012 Q2 | -18.69 Thousand CAD | 80.54% |
| 2012 Q1 | -96.05 Thousand CAD | -8.88% |
| 2012 Q4 | 100.34 Thousand CAD | 1741.46% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q4 | -88.21 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.28 Million CAD | -109.971% |
| Ayurcann Holdings Corp. | -3.96 Million CAD | -232.717% |
| Blueberries Medical Corp. | -1.63 Million CAD | -707.235% |
| The BC Bud Corporation | -1.22 Million CAD | -978.49% |
| BioNxt Solutions Inc. | -7.72 Million CAD | -70.937% |
| CordovaCann Corp. | -6.88 Million CAD | -91.75% |
| Christina Lake Cannabis Corp. | -4.13 Million CAD | -219.503% |
| Captor Capital Corp. | -11.38 Million CAD | -15.995% |
| City View Green Holdings Inc. | -2.44 Million CAD | -439.139% |
| 1CM Inc. | -913.85 Thousand CAD | -1344.572% |
| Global Hemp Group Inc. | -2.58 Million CAD | -411.573% |
| Greenway Greenhouse Cannabis Corporation | -4.72 Million CAD | -179.531% |
| IM Cannabis Corp. | -9.49 Million CAD | -38.991% |
| Lobe Sciences Ltd. | -4.7 Million CAD | -180.441% |
| Maple Leaf Green World Inc. | -1.09 Million CAD | -1109.436% |
| Mountain Valley MD Holdings Inc. | -7.67 Million CAD | -72.116% |
| Nextleaf Solutions Ltd. | 223.33 Thousand CAD | 6011.021% |
| Ovation Science Inc. | -813.14 Thousand CAD | -1523.481% |
| Captiva Verde Wellness Corp. | -6.08 Million CAD | -116.945% |
| RAMM Pharma Corp. | -7.72 Million CAD | -70.981% |
| RIV Capital Inc. | -106.76 Million CAD | 87.635% |
| Revive Therapeutics Ltd. | -5.61 Million CAD | -134.957% |
| Red White & Bloom Brands Inc. | -138.89 Million CAD | 90.496% |
| SLANG Worldwide Inc. | -19.36 Million CAD | 31.834% |
| 1933 Industries Inc. | -13.36 Million CAD | 1.217% |
| Red Light Holland Corp. | -7.62 Million CAD | -73.08% |
| Top Strike Resources Corp. | -1.72 Million CAD | -667.505% |
| Xebra Brands Ltd. | -1.95 Million CAD | -574.438% |
| Adastra Holdings Ltd. | -3.54 Million CAD | -272.43% |